Blood Tests & Laboratory

Blood is the one tissue in the body that touches every organ. It picks up chemicals released by the liver, waste products the kidneys have failed to clear, hormones from the thyroid and pituitary, antibodies the immune system has made against a virus, and the cells the bone marrow is producing right now. Draw a few millilitres of it and you are effectively sampling the running state of the whole system. That is why one small needle can answer questions about seven or eight different organs at once.

What blood cannot do is tell you what caused the number. A raised liver enzyme means liver cells are being damaged; it does not say whether the cause is alcohol, fatty liver, a virus, a medication or a supplement. A low haemoglobin means you are anaemic; it does not say whether you are losing blood, not absorbing iron, or not making red cells. The test narrows the field. The doctor, who has asked about your symptoms, examined you and knows what you have been treated for before, closes it.

This is the single most important thing to understand before you order tests for yourself. A panel bought off a menu without a consultation generates numbers with nobody to interpret them, and the most common outcome is not reassurance — it is anxiety about a mildly abnormal value that turns out to mean nothing, or false comfort from a normal value in a test that was never going to detect the thing you were worried about.

At Klinik Muhibbah we draw blood in-house and run the common tests on our own analyser, with the rest going to established partner laboratories. The clinic has been doing this in Masai since 1975, and Dr. Prabagaran Kanapathy and Dr. Kirubah Sai Patnaik review results themselves rather than handing you a printout at the counter. If a result needs action, you will hear about it from a doctor who can explain what happens next.

The thyroid gland sets the body's metabolic pace, and it goes wrong often enough — particularly in women — that thyroid testing is one of the most frequently requested investigations in general practice. The starting test is TSH, thyroid stimulating hormone, which is produced by the pituitary. It works as a thermostat: if the thyroid is underactive the pituitary pushes harder and TSH rises, and if the thyroid is overactive TSH is suppressed. Because it responds sensitively to small changes, TSH is usually abnormal before the thyroid hormones themselves are.

Free T4 is the main hormone the gland releases, and it is measured alongside TSH to establish how far the problem has gone. T3 is added when TSH is suppressed and hyperthyroidism is suspected, since a small number of people have a raised T3 with a normal T4. An underactive thyroid causes tiredness, weight gain, feeling cold, constipation, dry skin and low mood — a cluster easily mistaken for stress or depression. An overactive thyroid causes weight loss despite a good appetite, palpitations, tremor, heat intolerance, anxiety and loose stools. Both are eminently treatable once identified, and both need monitoring afterwards rather than a single test.

Reproductive hormones are a different matter, because timing changes the answer. FSH and LH fluctuate across the menstrual cycle, so a sample taken on the wrong day can be uninterpretable; where a cycle-timed sample is needed our nurses will tell you which day to come. Prolactin rises with stress, nipple stimulation and even the discomfort of the needle, so we ask you to sit quietly for a short period before the draw, and a borderline result is usually repeated before anything is concluded from it. Testosterone in men is best sampled in the morning when levels peak.

Vitamin B12, folate and calcium sit alongside these in the same request forms. B12 and folate deficiency cause anaemia with large red cells, and B12 deficiency can also cause numbness, tingling and memory changes that are worth catching early because nerve damage becomes less reversible with time. Vegetarians, people on long-term metformin and people who have had stomach surgery are the groups most likely to be low. Calcium is checked in bone disease, kidney disease and in people with recurrent stones, and an unexplained high calcium is always worth investigating properly rather than repeating indefinitely.

Anti-nuclear factor is a screening test for autoimmune disease such as lupus. It is a genuinely useful test in the right hands and a trap in the wrong ones, because a low-titre positive ANF is found in a meaningful proportion of entirely healthy people, particularly women, and rises further with age. We order it when the clinical picture — joint pains with rash, mouth ulcers, hair loss, unexplained inflammatory markers — actually warrants it, and refer to a physician when it is positive in that context.

The NS1 antigen test detects a protein made by the virus itself. It is at its most useful early — roughly the first five days of fever — and it can be positive on day one, before your body has had time to make any antibodies at all. This is what makes it valuable in a clinic setting: someone walks in on the second day of a high fever and we can often have an answer while they wait.

IgM and IgG antibodies appear later. IgM rises from around the fourth or fifth day and indicates a recent infection. IgG appears later still and, in someone with a compatible illness, a rising IgG can indicate a repeat infection with a different dengue serotype. The reason we frequently run the combined NS1 plus IgM/IgG test is that it covers both ends of that timeline, so a patient who is not sure exactly when their fever started does not get a falsely reassuring negative simply because they were tested on the wrong day.

A negative dengue test early in an illness never rules dengue out. If you are tested on day one and the result is negative but the fever continues, you need to be reviewed again — often the test is repeated and a full blood count is added, because a falling platelet count and a rising haematocrit are among the earliest objective signs that dengue is progressing. We would far rather see you twice than have you assume a single negative result settled the matter.

The most dangerous phase of dengue is not the peak of the fever. It is the period as the temperature comes down, usually somewhere between day three and day seven, when plasma can leak from the blood vessels. People feel like they are getting better and then deteriorate quickly. This is the window in which serial blood counts genuinely change outcomes, and it is why we ask dengue patients to come back for repeat testing rather than waiting to see how things go.

Tumour markers are substances — usually proteins — that can be raised in the blood of people with certain cancers. That sentence is where most marketing stops, and it is why people ask for a panel of markers as a general cancer check. But a marker being raised in people with cancer is not the same as a marker being able to find cancer in people who feel well. Those are two completely different statistical questions, and for these tests the answer to the second one is largely no.

The core problem is that these proteins are not exclusive to cancer. CA125 rises in endometriosis, fibroids, ovarian cysts, pelvic infection, liver disease, and simply during menstruation and pregnancy. CEA rises in smokers, in inflammatory bowel disease and in liver disease. AFP rises in pregnancy and in various forms of hepatitis. PSA rises with benign prostatic enlargement, with prostatitis, after a urinary infection, after cycling and after ejaculation. In a population of well people, the overwhelming majority of raised results come from these benign causes, not from cancer.

The consequence is not merely an unnecessary worry. A raised marker in a well person triggers a cascade: repeat tests, scans, referral, sometimes a biopsy with its own risks, and weeks or months of fear while it is all sorted out. Most of those cascades end with nothing being found, but the patient does not get those weeks back and the investigations are not risk-free.

The failure runs in the other direction too. Many people with early cancer have entirely normal markers, because these proteins usually rise only once disease is established and bulky. A normal CA125 does not exclude ovarian cancer. A normal CEA does not exclude bowel cancer. If you have symptoms — a change in bowel habit, blood in the stool, unexplained weight loss, a breast lump, persistent bloating, blood in the urine — a normal tumour marker must not be allowed to delay proper investigation, and this is precisely the scenario in which false reassurance does the most damage.

So when are they appropriate? They are genuinely valuable in three situations. First, in monitoring someone already diagnosed with cancer: if a marker was raised at diagnosis, tracking it afterwards is a good way to follow response to treatment and detect recurrence. Second, in investigating a specific abnormality that has already been found — a marker can help characterise an ovarian mass or a liver lesion seen on a scan. Third, in defined high-risk groups under specialist supervision, such as AFP with ultrasound surveillance in people with established cirrhosis or chronic hepatitis B.

PSA deserves its own note because it sits in a grey zone and men ask for it constantly. Prostate cancer screening with PSA does reduce prostate cancer deaths to a modest degree, but it also detects a large number of slow-growing cancers that would never have caused a problem in that man's lifetime, and treating those causes incontinence and erectile dysfunction in a proportion of men. The reasonable approach — and the one we take — is a conversation first: your age, your family history, your other health problems, and your own view on how you would want to act on an abnormal result. That discussion should happen before the blood is taken, not after the number comes back.

If your actual goal is to reduce your risk of dying of cancer, the evidence points somewhere else entirely: stopping smoking, cervical screening with Pap smear or HPV testing, mammography at the appropriate age, bowel screening with faecal occult blood testing, hepatitis B vaccination and treatment, and getting persistent symptoms looked at early. Our doctors will happily redirect you towards those, and they are the things a check-up here is built around.

The draw itself takes under a minute for most panels. A tourniquet goes on, the site is cleaned, and one needle fills however many tubes the requested tests need — you are not stuck once per test. Afterwards, press firmly on the cotton for a couple of minutes without bending the arm, which is the single best way to avoid a bruise. Bruising is harmless when it happens and fades over a week or so. Avoid heavy lifting with that arm for the rest of the day.

Walk-ins are welcome for blood tests during opening hours and no appointment is needed. If you are fasting, come early in the day. If you are booking a comprehensive panel or bringing a group of workers, calling ahead means we can have everything ready and get you through faster.

There is no single correct screening interval, because the right frequency depends on your age, your risk factors and what has been found before. What follows is a general orientation, not a prescription — the doctor will tailor it.

Healthy adults under forty with no risk factors, no symptoms and a normal weight get limited value from frequent broad panels. A baseline check every few years is reasonable, with blood pressure measured more often than that, since hypertension is common, entirely symptomless and easy to detect without a needle.

From forty onwards, and earlier for anyone of South Asian descent or with a strong family history of diabetes or heart disease, an annual or biennial check covering glucose or HbA1c, a lipid profile, renal function and liver function is sensible. This is the age band where the conditions that shorten Malaysian lives most — diabetes, hypertension, kidney disease and cardiovascular disease — start to become detectable long before they cause symptoms. Malaysians aged forty and above from B40 households may be eligible for subsidised screening under PEKA B40, which we are registered for.

People already diagnosed with diabetes need HbA1c roughly every three to six months depending on control, with renal function, urine albumin, lipids and a foot and eye check at least annually. People on long-term medication — statins, some antihypertensives, anti-epileptics, methotrexate, antipsychotics — need periodic monitoring specific to that drug, and the doctor prescribing it should tell you what and when.

Anyone with symptoms should be tested when the symptoms appear rather than waiting for a scheduled check-up. Persistent tiredness, unexplained weight loss, prolonged fever, unusual thirst and urination, breathlessness, blood anywhere it should not be, and a lump that is new or growing all warrant assessment now.

Workers requiring pre-employment, FOMEMA or statutory medical surveillance follow the schedule their employer or the relevant regulations set, which is a separate matter from personal health screening.